Oruka Therapeutics, Inc. · NASDAQ:ORKA

Sandler Laura Lee sold 600 Oruka Therapeutics, Inc. shares (Form 4)

Traded Jun 15, 2026 · Filed Jun 15, 2026

On Jun 15, 2026, Sandler Laura Lee (Chief Operating Officer) sold 600 Oruka Therapeutics, Inc. shares at US$69.69 for US$41,814, leaving 236,384 shares. Filed Jun 15, 2026 (Form 4).

Sold
600 shares
Price
US$69.69
Value
US$41,814
Holding after
236,384 shares
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Common StockSale600US$69.69236,384Direct

Source

View original at SEC

Related